Health TrialsbyHealthPanel

REgistRy BRAnch goRE EndopRosthEsis

ConditionsAortic Aneurysm, ThoracicAortic Dissection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Padova

About this trial

Multicenter registry on patients treated by the new Gore thoracic branched endoprosthesis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients receving the Gore TAG thoracic branched endograft for thoracic aorta pathologies

Disqualifiers

less than 18 years

allergy to endograft components

patients receiving other types of arch endografts

Trial population

All consecutive patients treated with the Gore TAG thoracic branched endograft in the participating centers

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • GORE TAG Thoracic Branch Endoprosthesis

    Device

    deployment of the GORE TAG Thoracic Branch Endoprosthesis fro thoraci aorta pathologies

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

early mortality

mortality related to the intervention within 30 days

Time frame
30 days
2

device stability

freedom from related mortality, reintervention, type 1a endoleak during follow-up

Time frame
5 years
3

technical success

succesful deployment of all endograft components at the intended site with complete aneurysm exclusion, without surgical conversion, type Ia/III endoleak, kink, stenosis, graft occlusion

Time frame
30 days

Secondary outcomes

1

early major adverse events

stroke, spinal cord ischemia, vascular complications, cardiac complications, respiratory insufficiency, early reintervention, acute kidney injury

Time frame
30 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital Padova

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: